Hamill John P.

EDGAR CIK 0001716213

Aprea Therapeutics, Inc. - APRE

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
CFO
SrVP/CFO/Prin Fin & Acct Ofcr
Direct Buys
1
$5,825
5,000 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
12/10/2025
12/11/2025
Buy
5,000 @ $1.17
 $5,825 27,733 (21.99%) Direct